Support excellence in cancer care, research, and training.
Your gift gives hope to patients and families by supporting vital services and the people who provide them, fueling innovations that will transform the future of cancer screening, care, and prevention, and training the next generation of healthcare leaders.
Cancer Statistics
4,500
newly diagnosed patients are seen each year at Dartmouth Cancer Center’s 14 locations.
240+
active clinical trials, including national and multi-center trials, are underway at Dartmouth Cancer Center.
135+
Cancer Center investigators lead research studies in cancer biology, causes, prevention, and treatment.
Cancer Testimonial
There’s an incredible sense of community, here—of neighbors taking care of neighbors—and a shared passion for doing whatever it takes to improve the lives of patients in our clinics and around the world.
An Individualized Approach to Preventing Cancer Before It Starts
What if a physician could deliver effective, personalized strategies to stop cancer before it starts? With your support, multidisciplinary teams of physicians, researchers, computer scientists, engineers, entrepreneurs, social workers, app developers, and patients at Dartmouth Cancer Center are together making precision cancer prevention a reality.
Leveraging the Body’s Brilliance to Fight Cancer
Cancer immunotherapy trains the immune system to recognize and attack malignant cells. By supporting the field’s brightest minds, many of whom are at Dartmouth, you will help advance their growing understanding of the delicate relationship between tumors and immune cells into safe and potent therapies. A potentially more sustainable approach than conventional treatments, immunotherapy holds the key to curing, not just treating, cancer.
Backing Entrepreneurs. Igniting Discovery. Fueling Hope.
The Dartmouth Innovation Accelerator for Cancer (DIAC) was launched in 2020 with a bold goal: bring the best cancer therapies to market, faster. Powered by an extensive and dedicated network of alumni from across Dartmouth, DIAC exists to quicken the pace of cancer research, nurture innovative discoveries through the development pipeline, and offer hope to patients and families. Join us in supporting this pioneering venture.
Where the Clinic and the Dinner Table Meet
Nearly 22% of Dartmouth Cancer Center patients are food insecure, and sometimes must choose between sustenance and treatment. Healing Harvest, a new food pantry within the Cancer Center, delivers a solution to our community.
Providing Hope for Patients with Triple-Negative Breast Cancer
The Triple-Negative Breast Cancer Research Fund aims to directly fund and advance the work of Linda Vahdat, MD, MBA, section chief of oncology and deputy director of Dartmouth Cancer Center, to treat and prevent the recurrence of triple-negative breast cancer and potentially other cancers.
Hope Starts Here.
The Prouty is northern New England's largest family-friendly fundraising event combining cycling, walking, rowing, golf and more to raise funds and awareness for life-saving research and critical patient and family support services at Dartmouth Cancer Center. The Prouty is produced by the Friends of Dartmouth Cancer Center, and has raised more than $68 million since its inception more than 40 years ago.
Cancer Testimonial
The Prouty is a splendid event that inspired me to give additional support to the Cancer Center. I encourage others to get involved with the Prouty—you’ll be moved by the experience, as I was.”
About Dartmouth Cancer Center
Dartmouth Cancer Center combines advanced cancer research at Dartmouth and the Geisel School of Medicine, with award-winning, personalized, and compassionate patient-centered cancer care and clinical trials based at Dartmouth Health's Dartmouth Hitchcock Medical Center. With 14 locations around New Hampshire and Vermont, Dartmouth Cancer Center is one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers. Each year the Dartmouth Cancer Center schedules 74,000 appointments seeing more than 4,500 newly diagnosed patients, and currently offers patients more than 240 active clinical trials. We strive to prevent and cure cancer, enhance survivorship, and to promote cancer health equity through pioneering interdisciplinary research and collaborations.
